Artemether suppresses cell proliferation and induces apoptosis in diffuse large B cell lymphoma cells

Zhao,Xinying; Guo,Xudong; Yue,Wenqin; Wang,Jianmin; Yang,Jianmin; Chen,Jie

doi:10.3892/etm.2017.5063

Artemether suppresses cell proliferation and induces apoptosis in diffuse large B cell lymphoma cells

Authors:
- Xinying Zhao
- Xudong Guo
- Wenqin Yue
- Jianmin Wang
- Jianmin Yang
- Jie Chen
View Affiliations

Affiliations: Department of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200168, P.R. China, Clinical and Translational Research Centre of Shanghai First Maternity & Infant Health Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Collaborative Innovation Centre for Brain Science, School of Life Science and Technology, Tongji University, Shanghai 200092, P.R. China
Published online on: August 29, 2017 https://doi.org/10.3892/etm.2017.5063
Pages: 4083-4090
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Artemether (ART), a derivative of the well‑known anti‑malaria drug artemisinin, demonstrates potent anti‑cancer activity in various cancer cells, however its effects on lymphoma remain unknown. The present study demonstrated that ART significantly inhibited proliferation of diffuse large B cell lymphoma (DLBCL) in vivo and in vitro, and led to G0/G1 phase arrest. Mechanistic studies demonstrated that ART suppressed the expression of the cell cycle proteins cyclin dependent kinase (CDK) 2, 4, and Cyclin D1, and specifically repressed the proto‑oncogene c‑Myc, rather than regulating the extracellular signal‑regulated kinase or protein kinase B signaling pathways (two key pathways involved in regulating cell proliferation). In addition, high‑concentration ART treatment significantly induced the apoptosis of DLBCL cells by promoting the cleavage of Caspase‑3 and Poly (ADP‑ribose) polymerase (PARP) 1. Overall, the data indicated that ART exhibited anti‑cancer activity by inhibiting the expression of cell cycle genes and c‑Myc, and promoting Caspase‑3 and PARP1 cleavage, which suggested that ART may serve as a dual pharmaceutical for the treatment DLBCL.

View Figures

View References

1	Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Fermé C, Christian B, Lepage E, Tilly H, Morschhauser F, et al: Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 23:4117–4126. 2005. View Article : Google Scholar : PubMed/NCBI
2	Grandesso F, Nabasumba C, Nyehangane D, Page AL, Bastard M, De Smet M, Boum Y and Etard JF: Performance and time to become negative after treatment of three malaria rapid diagnostic tests in low and high malaria transmission settings. Malar J. 15:4962016. View Article : Google Scholar : PubMed/NCBI
3	Jia G, Kong R, Ma ZB, Han B, Wang YW, Pan SH, Li YH and Sun B: The activation of c-Jun NH₂-terminal kinase is required for dihydroartemisinin-induced autophagy in pancreatic cancer cells. J Exp Clin Cancer Res. 33:82014. View Article : Google Scholar : PubMed/NCBI
4	Shahbazfar AA, Zare P, Ranjbaran M, Tayefi-Nasrabadi H, Fakhri O, Farshi Y, Shadi S and Khoshkerdar A: A survey on anticancer effects of artemisinin, iron, miconazole, and butyric acid on 5637 (bladder cancer) and 4T1 (Breast cancer) cell lines. J Cancer Res Ther. 10:1057–1062. 2014. View Article : Google Scholar : PubMed/NCBI
5	Wu ZP, Gao CW, Wu YG, Zhu QS, Yan Chen, Xin Liu and Chuen Liu: Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model. Integr Cancer Ther. 8:88–92. 2009. View Article : Google Scholar : PubMed/NCBI
6	Gerhardt T, Jones R, Park J, Lu R, Chan HW, Fang Q, Singh N and Lai H: Effects of antioxidants and pro-oxidants on cytotoxicity of dihydroartemisinin to Molt-4 human leukemia cells. Anticancer Res. 35:1867–1871. 2015.PubMed/NCBI
7	Krishna S, Ganapathi S, Ster IC, Saeed ME, Cowan M, Finlayson C, Kovacsevics H, Jansen H, Kremsner PG, Efferth T and Kumar D: A randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer. EBioMedicine. 2:82–90. 2015. View Article : Google Scholar : PubMed/NCBI
8	Michaelsen FW, Saeed ME, Schwarzkopf J and Efferth T: Activity of Artemisia annua and artemisinin derivatives, in prostate carcinoma. Phytomedicine. 22:1223–1231. 2015. View Article : Google Scholar : PubMed/NCBI
9	Shterman N, Kupfer B and Moroz C: Comparison of transferrin receptors, iron content and isoferritin profile in normal and malignant human breast cell lines. Pathobiology. 59:19–25. 1991. View Article : Google Scholar : PubMed/NCBI
10	Efferth T, Benakis A, Romero MR, Tomicic M, Rauh R, Steinbach D, Häfer R, Stamminger T, Oesch F, Kaina B and Marschall M: Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic Biol Med. 37:998–1009. 2004. View Article : Google Scholar : PubMed/NCBI
11	Ooko E, Saeed ME, Kadioglu O, Sarvi S, Colak M, Elmasaoudi K, Janah R, Greten HJ and Efferth T: Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. Phytomedicine. 22:1045–1054. 2015. View Article : Google Scholar : PubMed/NCBI
12	Carmeliet P and Jain RK: Molecular mechanisms and clinical applications of angiogenesis. Nature. 473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
13	Pang Y, Qin G, Wu L, Wang X and Chen T: Artesunate induces ROS-dependent apoptosis via a Bax-mediated intrinsic pathway in Huh-7 and Hep3B cells. Exp Cell Res. 347:251–260. 2016. View Article : Google Scholar : PubMed/NCBI
14	Stine ZE, Walton ZE, Altman BJ, Hsieh AL and Dang CV: MYC, metabolism, and cancer. Cancer Discov. 5:1024–1039. 2015. View Article : Google Scholar : PubMed/NCBI
15	Che N, Ma Y and Xin Y: Protective role of fucoidan in cerebral ischemia-reperfusion injury through inhibition of MAPK signaling pathway. Biomol Ther (Seoul). 25:272–278. 2017. View Article : Google Scholar : PubMed/NCBI
16	Guo JR, Li W, Wu Y, Wu LQ, Li X, Guo YF, Zheng XH, Lian XL, Huang HF and Chen YZ: Hepatocyte growth factor promotes proliferation, invasion, and metastasis of myeloid leukemia cells through PI3K-AKT and MAPK/ERK signaling pathway. Am J Transl Res. 8:3630–3644. 2016.PubMed/NCBI
17	Roskoski R Jr: Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs. Pharmacol Res. 107:249–275. 2016. View Article : Google Scholar : PubMed/NCBI
18	Shapiro GI: Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol. 24:1770–1783. 2006. View Article : Google Scholar : PubMed/NCBI
19	Park YG, Park S, Lim SO, Lee MS, Ryu CK, Kim I and Cho-Chung Y: Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide. Biochem Biophys Res Comm. 281:1213–1219. 2001. View Article : Google Scholar : PubMed/NCBI
20	Chohan TA, Qian H, Pan Y and Chen JZ: Cyclin-dependent kinase-2 as a target for cancer therapy: Progress in the development of CDK2 inhibitors as anti-cancer agents. Curr Med Chem. 22:237–263. 2015. View Article : Google Scholar : PubMed/NCBI
21	Hargraves KG, He L and Firestone GL: Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells. Mol Carcinog. 55:486–498. 2016. View Article : Google Scholar : PubMed/NCBI
22	Odaka Y, Xu B, Luo Y, Shen T, Shang C, Wu Y, Zhou H and Huang S: Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells. Carcinogenesis. 35:192–200. 2014. View Article : Google Scholar : PubMed/NCBI
23	Hu W, Chen SS, Zhang JL, Lou XE and Zhou HJ: Dihydroartemisinin induces autophagy by suppressing NF-κB activation. Cancer Lett. 343:239–248. 2014. View Article : Google Scholar : PubMed/NCBI
24	Kim HG, Yang JH, Han EH, Choi JH, Khanal T, Jeong MH, Jeong TC and Jeong HG: Inhibitory effect of dihydroartemisinin against phorbol ester-induced cyclooxygenase-2 expression in macrophages. Food Chem Toxicol. 56:93–99. 2013. View Article : Google Scholar : PubMed/NCBI
25	Lu JJ, Meng LH, Shankavaram UT, Zhu CH, Tong LJ, Chen G, Lin LP, Weinstein JN and Ding J: Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells. Biochem Pharmacol. 80:22–30. 2010. View Article : Google Scholar : PubMed/NCBI
26	Morrissey C, Gallis B, Solazzi JW, Kim BJ, Gulati R, Vakar-Lopez F, Goodlett DR, Vessella RL and Sasaki T: Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells. Anticancer Drugs. 21:423–432. 2010. View Article : Google Scholar : PubMed/NCBI
27	Chung TW, Choi H, Lee JM, Ha SH, Kwak CH, Abekura F, Park JY, Chang YC, Ha KT, Cho SH, et al: Oldenlandia diffusa suppresses metastatic potential through inhibiting matrix metalloproteinase-9 and intercellular adhesion molecule-1 expression via p38 and ERK1/2 MAPK pathways and induces apoptosis in human breast cancer MCF-7 cells. J Ethnopharmacol. 195:309–317. 2017. View Article : Google Scholar : PubMed/NCBI
28	Youn DH, Park J, Kim HL, Jung Y, Kang JW, Jeong MY, Sethi G, Ahn KS and Um JY: Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase. Oncotarget. 8:9500–9512. 2017.PubMed/NCBI
29	Zuo WH, Zeng P, Chen X, Lu YJ, Li A and Wu JB: Promotive effects of bone morphogenetic protein 2 on angiogenesis in hepatocarcinoma via multiple signal pathways. Sci Rep. 6:374992016. View Article : Google Scholar : PubMed/NCBI
30	Feng X, Jiang J, Shi S, Xie H, Zhou L and Zheng S: Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway. Int J Oncol. 49:2600–2610. 2016. View Article : Google Scholar : PubMed/NCBI
31	Gao Y, Xiao X, Zhang C, Yu W, Guo W, Zhang Z, Li Z, Feng X, Hao J, Zhang K, et al: Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways. J Pineal Res. 62:2017.doi: 10.1111/jpi.12380. View Article : Google Scholar
32	Wang L, Zhang S, Cheng H, Lv H, Cheng G and Ci X: Nrf2-mediated liver protection by esculentoside A against acetaminophen toxicity through the AMPK/Akt/GSK3β pathway. Free Radic Biol Med. 101:401–412. 2016. View Article : Google Scholar : PubMed/NCBI
33	Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY, Harousseau JL, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 333:1540–1545. 1995. View Article : Google Scholar : PubMed/NCBI
34	Reungpatthanaphong P and Mankhetkorn S: Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines. Biol Pharm Bull. 25:1555–1561. 2002. View Article : Google Scholar : PubMed/NCBI